Posterior reversible encephalopathy syndrome after high-dose cytarabine in acute myelogenous leukemia

被引：2
|
作者：
Newey, Christopher R. [1 ]
Chandrasekaran, Premkumar N. [1 ]
Mohebbi, Mohammad R. [2 ]
机构：
[1] Univ Missouri, Dept Neurol, Columbia, MO USA
[2] Univ Missouri, Dept Emergency Med, Columbia, MO USA
来源：
NEUROLOGY INDIA | 2017年 / 65卷 / 01期
关键词：
D O I：
10.4103/0028-3886.198171
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：220 / 220
页数：1
相关论文
共 50 条
  • [1] HIGH-DOSE CYTARABINE IN ACUTE MYELOGENOUS LEUKEMIA
    ZITTOUN, R
    [J]. BONE MARROW TRANSPLANTATION, 1989, 4 : 38 - 42
  • [2] High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia
    Cortes, J
    Estey, E
    O'Brien, S
    Giles, F
    Shen, Y
    Koller, C
    Beran, M
    Thomas, D
    Keating, M
    Kantarjian, H
    [J]. CANCER, 2001, 92 (01) : 7 - 14
  • [3] Behenoyl cytarabine-associated reversible encephalopathy in a patient with acute myelogenous leukemia
    Cho, SG
    Moon, H
    Lee, JH
    Lee, SY
    Kim, CC
    Lee, KS
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 1999, 14 (01) : 89 - 92
  • [4] POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN ACUTE CHILDHOOD LEUKEMIA
    Lee, I. G.
    Kim, S. J.
    Yoon, D. H.
    Chung, N. G.
    Cho, B.
    Im, S. A.
    [J]. EPILEPSIA, 2017, 58 : S59 - S59
  • [5] HIGH-DOSE CYTARABINE FOR THE TREATMENT OF BLASTIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
    HERZIG, RH
    PHILLIPS, GL
    LAZARUS, HM
    WOLFF, SN
    HERZIG, GP
    [J]. CANCER TREATMENT REPORTS, 1985, 69 (7-8): : 881 - 883
  • [6] BENEFIT OF HIGH-DOSE CYTARABINE-BASED CONSOLIDATION CHEMOTHERAPY FOR ADULTS WITH ACUTE MYELOGENOUS LEUKEMIA
    SCHILLER, G
    GAJEWSKI, J
    LEE, M
    HO, W
    TERRITO, M
    CHAMPLIN, R
    [J]. LEUKEMIA & LYMPHOMA, 1994, 15 (1-2) : 85 - 90
  • [7] IDARUBICIN PLUS CONTINUOUS-INFUSION HIGH-DOSE CYTARABINE AS TREATMENT FOR PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROME
    ESTEY, EH
    KANTARJIAN, H
    KEATING, M
    [J]. SEMINARS IN ONCOLOGY, 1993, 20 (06) : 1 - 5
  • [8] HIGH-DOSE CYTARABINE AND DAUNORUBICIN INDUCTION AND POSTREMISSION CHEMOTHERAPY FOR THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA IN ADULTS
    PHILLIPS, GL
    REECE, DE
    SHEPHERD, JD
    BARNETT, MJ
    BROWN, RA
    FREILAHR, DA
    KLINGEMANN, HG
    BOLWELL, BJ
    SPINELLI, JJ
    HERZIG, RH
    HERZIG, GP
    [J]. BLOOD, 1991, 77 (07) : 1429 - 1435
  • [9] PHASE-II STUDY OF AMSACRINE AND HIGH-DOSE CYTARABINE FOR RESISTANT ACUTE MYELOGENOUS LEUKEMIA
    DECKER, RW
    HO, WG
    CHAMPLIN, RE
    [J]. CANCER TREATMENT REPORTS, 1987, 71 (09): : 881 - 882
  • [10] Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia
    Saito, Bungo
    Nakamaki, Tsuyoshi
    Nakashima, Hidetoshi
    Usui, Takako
    Hattori, Norimichi
    Kawakami, Keiichiro
    Tomoyasu, Shigeru
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (04) : 304 - 306
12345